Discontinued — last reported Q4 '25
Humana Unrealized Gains on Investments decreased by 45.7% to $25.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.6%, from $36.00M to $25.00M. Over 3 years (FY 2022 to FY 2025), Unrealized Gains on Investments shows an upward trend with a 72.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase reflects positive market performance of the company's investment portfolio, potentially signaling hidden value in non-core assets.
This represents the cumulative increase in the fair value of investment securities that have not yet been sold. These ga...
Highly dependent on the composition of the investment portfolio and broader equity or bond market conditions.
unrealized_gains_on_investments| Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.00M | $35.00M | $13.00M | $34.00M | $27.00M | $30.00M | $152.00M | $26.00M | $36.00M | $52.00M | $55.00M | $46.00M | $25.00M |
| QoQ Change | — | +288.9% | -62.9% | +161.5% | -20.6% | +11.1% | +406.7% | -82.9% | +38.5% | +44.4% | +5.8% | -16.4% | -45.7% |
| YoY Change | — | — | — | +277.8% | -22.9% | +130.8% | — | -23.5% | +33.3% | +73.3% | -63.8% | +76.9% | -30.6% |